Enable Injections Announces Regulatory Approval in Saudi Arabia for the EMPAVELI(R) Injector based on enFuse(R) Technology
Enable Injections Announces Regulatory Approval in Saudi Arabia for the EMPAVELI(R) Injector based on enFuse(R) Technology GlobeNewswire December 18, 2025 CINCINNATI, Dec. 18, 2025 (GLOBE NEWSWIRE) — Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse(R) On-Body Delivery System, today announced that the EMPAVELI(R) Injector, based on enFuse technology, has received […]